Efficacy Study of Two Treatments in the Remission of Vasculitis
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
Study of the efficacy of rituximab for maintenance treatment in systemic ANCA-associated
vasculitis: prospective, multicenter, controlled, randomized comparative study of rituximab
versus azathioprine